Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14851
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pradidarcheep W. | |
dc.date.accessioned | 2021-04-05T04:31:58Z | - |
dc.date.available | 2021-04-05T04:31:58Z | - |
dc.date.issued | 2008 | |
dc.identifier.issn | 13685538 | |
dc.identifier.other | 2-s2.0-45849140201 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14851 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-45849140201&doi=10.1080%2f13685530801954026&partnerID=40&md5=38fd859477a0e456809c781593e8588b | |
dc.description.abstract | The study of the health status of the aging male takes presently a more integrative approach and it appears that ailments typical of male aging, such as lower urinary tract symptoms (LUTS), (visceral) obesity, metabolic syndrome and erectile failure are significantly interrelated. A common denominator of the above ailments is lower-than-normal testosterone levels occurring in a significant proportion of elderly men. This review addresses the potential connections between LUTS and late-onset hypogonadism. In animal studies there appear to be androgen and estrogen receptors in the urothelium and smooth muscle cells of the urethra and bladder of the rat and rabbit, as well as in the neurons in the autonomic ganglia of the prostatic plexus of the male rat. Upon castration electrically evoked relaxations of the smooth muscle of the prostatic urethra were decreased. There is a Rho-kinase activation/endothelin pathway; possibly involved in the increased smooth muscle activity found in both LUTS/benign prostate hyperplasia. Nitric oxide (NO) appears to have a smooth muscle relaxing effect in the urogenital organs. Studies in humans have convincingly shown that phosphodiestererase inhibitors have a beneficial effect on LUTS. More intervention studies should be undertaken to test the clinical validity of the theoretically plausible interrelationship between LUTS and late-onset hypogonadism. © 2008 Informa UK Ltd. | |
dc.subject | androgen receptor | |
dc.subject | angiotensin II | |
dc.subject | endothelin | |
dc.subject | estrogen receptor | |
dc.subject | nitric oxide | |
dc.subject | Rho kinase | |
dc.subject | testosterone | |
dc.subject | aging | |
dc.subject | castration | |
dc.subject | disease course | |
dc.subject | enzyme activation | |
dc.subject | enzyme activity | |
dc.subject | human | |
dc.subject | hypogonadism | |
dc.subject | lower urinary tract symptom | |
dc.subject | nonhuman | |
dc.subject | note | |
dc.subject | priority journal | |
dc.subject | prostate hypertrophy | |
dc.subject | Age of Onset | |
dc.subject | Aging | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Hypogonadism | |
dc.subject | Intra-Abdominal Fat | |
dc.subject | Male | |
dc.subject | Metabolic Syndrome X | |
dc.subject | Nitric Oxide | |
dc.subject | Rabbits | |
dc.subject | Rats | |
dc.subject | Receptors, Androgen | |
dc.subject | Testosterone | |
dc.subject | Urinary Tract | |
dc.subject | Urination Disorders | |
dc.title | Lower urinary tract symptoms and its potential relation with late-onset hypogonadism | |
dc.type | Note | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Aging Male. Vol 11, No.2 (2008), p.51-55 | |
dc.identifier.doi | 10.1080/13685530801954026 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.